Clinical Trial Update: Cocoa Flavanols in Renal Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 study evaluating cocoa flavanols in patients with end-stage renal disease and endothelial dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Endothelial Dysfunction

Drugs mentioned

• Cocoa flavanols (cocoa flavanols extract)

Snippet

Sponsor: Klinik für Kardiologie, Pneumologie und Angiologie | Conditions: End Stage Renal Disease, Endothelial Dysfunction | Phase 1, Phase 2 | Status: COMPLETED